Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gandini

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|February 28, 2019
Who, why, where: an overview of determinants of sunbed use in EuropeM Suppa, S Gandini, J L Bulliard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 9, 2023
EUSCAP: A Euromelanoma project to investigate skin cancer risk factors in EuropeK Wunderlich, M Suppa, J Lipski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 6, 2006
Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of OncologyO Gentilini, G Trifirò, J Soteldo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2019
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 22, 2019
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Breast Cancer Research and Treatment|February 22, 2012
Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible?F Didier, P Arnaboldi, S Gandini, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of the European Academy of Dermatology and Venereology : JEADV|February 28, 2019
Who, why, where: an overview of determinants of sunbed use in EuropeM Suppa, S Gandini, J L Bulliard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 9, 2023
EUSCAP: A Euromelanoma project to investigate skin cancer risk factors in EuropeK Wunderlich, M Suppa, J Lipski, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 6, 2006
Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of OncologyO Gentilini, G Trifirò, J Soteldo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2019
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 22, 2019
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Breast Cancer Research and Treatment|February 22, 2012
Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible?F Didier, P Arnaboldi, S Gandini, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Pageof 8